Table:
begin	end	state
1	8	cytoplasmic
9	31	transmembrane
32	55	non-cytoplasmic
56	76	transmembrane
77	82	cytoplasmic
83	102	transmembrane
103	107	non-cytoplasmic
108	131	transmembrane
132	150	cytoplasmic
151	170	transmembrane
171	199	non-cytoplasmic
200	220	transmembrane
221	246	cytoplasmic
247	271	transmembrane
272	284	non-cytoplasmic
285	305	transmembrane
306	312	cytoplasmic
313	331	transmembrane
332	336	non-cytoplasmic
337	358	transmembrane
359	368	cytoplasmic
369	390	transmembrane
391	396	non-cytoplasmic
397	418	transmembrane
419	442	cytoplasmic

Input:
>WP_101445153.1 NCBI__GCF_002846395.1:WP_101445153.1
MHTAPRKNFLLAPGTLGPFILVTSLFFLWGLANNMTDTLLAAFKRIMSMSDFQTSWIQMA
FYGAYFCLALPAAILIKKYSYKTGILVGLGLFILGALLFYPASLTLSYGYFLVALYVLAG
GLSILETAANPYIVAMGPAESGTRRLNLAQSFNPIGSISGVLLSKVFILSQLNQLNAEER
SGLNADELAAVQSEELTAVMGPYVGIALFLVLLWGVLYFTRMPKASDTDSKVELAATFSR
LVRTPNYVWAVVAQFFYVGAQIGVWSFTIRYVMLELRLNESDASTYYMASLVLFMASRFA
FTALMKFIQPKTLLFATAIAAAALTLVVIYGNGPAGVYALIGISGCMSLMFPTIYGLGIR
GLGEDTKIGGSGLIMAILGGAILTSVQGYVSDLTQDIGLAFYVPLLCFLVIALYAFVAEK
PEIAARKKEADALVTQPVTSVL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server